PH

PHOENIX INTERNATIONAL LIFE SCIENCES INC

  • CIK: 0000935016
  • EIN: 22-3209631
  • Business address: 2350 COHEN STREET, ST LAURENT QUEBEC, H4R 2P7 CANADA, A8, 00000

Information

  • Mailing address
  • Phone
    N/A
  • State location
    A8
  • State of incorporation
    N/A
  • Fiscal year end
    August 31
  • SIC
    8071 - (CF Office: Office of Life Sciences) SERVICES-MEDICAL LABORATORIES
  • Filings
    N/A

About PHOENIX INTERNATIONAL LIFE SCIENCES INC

PHOENIX INTERNATIONAL LIFE SCIENCES INC (CIK: 0000935016) is an American company incorporated in the state of A8. Head office is located at 2350 COHEN STREET, ST LAURENT QUEBEC, H4R 2P7 CANADA, A8, 00000. Work in the industry 8071 - (CF Office: Office of Life Sciences) SERVICES-MEDICAL LABORATORIES. PHOENIX INTERNATIONAL LIFE SCIENCES INC is a public company and trade via Over-The-Counter (OTC).

Ownership

Updating!

Stock Chart

Coming soon!

Jobs

Coming soon!

Recent SEC Filings

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by PHOENIX INTERNATIONAL LIFE SCIENCES INC

Filings Format Description Filed/Effective File/Film Number
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001036050-00-000308 ( Act) Size: 7 KB		 Mar-03-2000

000-29942

560849
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001036050-00-000253 ( Act) Size: 15 KB		 Feb-24-2000

000-29942

552779
425 Document

Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Acc-no: 0001036050-00-000252 ( Act) Size: 10 KB		 Feb-24-2000

000-29942

552730
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001036050-00-000238 ( Act) Size: 6 KB		 Feb-24-2000

000-29942

552159
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001036050-00-000077 ( Act) Size: 25 KB		 Feb-01-2000

000-29942

519198
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001036050-00-000040 ( Act) Size: 8 KB		 Jan-14-2000

000-29942

507572
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001036050-00-000016 ( Act) Size: 13 KB		 Jan-11-2000

000-29942

505079
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001036050-99-002492 ( Act) Size: 7 KB		 Dec-10-1999

000-29942

99772489
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0000950123-99-010890 ( Act) Size: 322 KB		 Dec-10-1999

000-29942

99772954
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001036050-99-002466 ( Act) Size: 11 KB		 Dec-01-1999

000-29942

99767381
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001036050-99-002363 ( Act) Size: 8 KB		 Nov-12-1999

000-29942

99749631
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0000912057-99-003340 ( Act) Size: 6 KB		 Nov-03-1999

000-29942

99740563
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0000912057-99-003099 ( Act) Size: 29 KB		 Nov-02-1999

000-29942

99739285
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0000912057-99-001651 ( Act) Size: 6 KB		 Oct-20-1999

000-29942

99730977
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001047469-99-035894 ( Act) Size: 10 KB		 Sep-15-1999

000-29942

99712227
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001047469-99-027628 ( Act) Size: 21 KB		 Jul-15-1999

000-29942

99665139
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001047469-99-018243 ( Act) Size: 10 KB		 May-05-1999

000-29942

99610955
S-8 Document

Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Acc-no: 0001047469-99-018018 ( Act) Size: 29 KB		 May-04-1999

333-77745

99610367
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001047469-99-016036 ( Act) Size: 8 KB		 Apr-23-1999

000-29942

99599608
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001047469-99-015187 ( Act) Size: 25 KB		 Apr-16-1999

000-29942

99595552

Recent 20 filings. View all PHOENIX INTERNATIONAL LIFE SCIENCES INC filings

Reviews

Overall rating 5.0

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Frequently Asked Questions

Tags:

  • PHOENIX INTERNATIONAL LIFE SCIENCES INC overview
  • PHOENIX INTERNATIONAL LIFE SCIENCES INC job
  • PHOENIX INTERNATIONAL LIFE SCIENCES INC stock
  • PHOENIX INTERNATIONAL LIFE SCIENCES INC ownership
  • PHOENIX INTERNATIONAL LIFE SCIENCES INC CEO
  • PHOENIX INTERNATIONAL LIFE SCIENCES INC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.

Orther Companies

Advanced Biomed Inc.
Update: May 23, 2023
Fortrea Holdings Inc.
Update: May 16, 2023
LUDWIG ENTERPRISES, INC.
Update: Apr 26, 2023
WORKPLACE COMPLIANCE INC
Update: Aug 25, 2022
WEAVIL DAVID C
Update: Aug 25, 2022
UROCOR INC
Update: Aug 24, 2022

Latest News

SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate Conflicts of Interest
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
SEC Press Releases  Nov 17, 2023 2942 Views
Charter Communications to Pay $25 Million Penalty for Unauthorized Stock Buybacks
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Press Releases  Nov 15, 2023 1093 Views
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Press Releases  Nov 15, 2023 4109 Views
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries for Falsifying Documents While Raising $70 Million From Investors
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Press Releases  Nov 10, 2023 3862 Views
SEC Charges Royal Bank of Canada with Internal Accounting Controls Violations
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Press Releases  Nov 03, 2023 4213 Views
SEC Charges President/CCO of Prophecy Asset Management Advisory Firm with Multi-Year Fraud
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Press Releases  Nov 03, 2023 3709 Views
SEC Adopts Rules for the Registration and Regulation of Security-Based Swap Execution Facilities
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Press Releases  Nov 02, 2023 2864 Views
SEC Charges Crypto Company SafeMoon and its Executive Team for Fraud and Unregistered Offering of Crypto Securities
SEC Charges Crypto Company SafeMoon and its Executive Team for...
SEC Press Releases  Nov 01, 2023 2523 Views
SEC Charges Four Long Island Men with Perpetrating $2 Million “Free-Riding” Scheme
SEC Charges Four Long Island Men with Perpetrating $2 Million...
SEC Press Releases  Nov 01, 2023 1502 Views

© 2022 CompaniesBIO.Com. All rights reserved. Operated by